Results 121 to 130 of about 2,013 (145)
Some of the next articles are maybe not open access.
Indolent systemic mastocytosis: is there a reliable radiographic pattern?
Pediatric Radiology, 2012A 14-year-old boy undergoing treatment for nephrotic syndrome with steroids and cyclosporine presented with small sclerotic bone lesions in a routine chest radiograph. Similar lesions were found in other bones of the axial and appendicular skeleton. Despite the paucity of clinical symptoms and absence of laboratory data suggesting systemic mastocytosis,
Flávia Silva, Braga +4 more
openaire +2 more sources
High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis
Allergy, 2012AbstractBackground: Indolent systemic mastocytosis (ISM) is a rare disease characterized by accumulation of abnormal mast cells in various tissues, including bone marrow. Symptoms are usually related to release of mast cell mediators. The aims are to establish the prevalence of osteoporotic fractures in ISM and to investigate the association with serum
van der Veer, E. +4 more
openaire +2 more sources
Demystifying the diagnostic criteria of indolent systemic mastocytosis
Hematological Oncology, 2021Federica Irene Grifoni +11 more
openaire +2 more sources
INDOLENT SYSTEMIC MASTOCYTOSIS: AN INCIDENTAL DIAGNOSIS
Annals of Allergy, Asthma & Immunology, 2023A. Khalid +3 more
openaire +1 more source
[Indolent systemic mastocytosis : an overview in 2025].
Revue medicale suisseMast cells (MC) play an important role in the defense against microbial agents, parasites and venoms. The term mastocytosis encompasses a group of diseases characterized by abnormal MC accumulation, divided into cutaneous and systemic forms. The diagnosis of indolent systemic mastocytosis (ISM) is supported by the presence of MC clusters in bone marrow
Julien, Dereme +3 more
openaire +1 more source
Avapritinib for the Treatment of Indolent Systemic Mastocytosis
Clinical Immunology, 2023Samer Abdelkader, Weyman Lam
openaire +1 more source
EPH79 Epidemiology of Systemic Mastocytosis (SM) and Indolent Systemic Mastocytosis (ISM) in Germany
Value in Health, 2023M. Herold +3 more
openaire +1 more source
Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?
Journal of Allergy and Clinical Immunology, 2022Cem Akin, Michel Arock, Peter Valent
exaly
INDOLENT SYSTEMIC MASTOCYTOSIS PRESENTING AS AN EXCIPIENT ALLERGY
Annals of Allergy, Asthma & Immunology, 2022L. Franzblau, D. Khan
openaire +1 more source
Indolent systemic mastocytosis.
The Israel Medical Association journal : IMAJ, 2010Sergio, Vano-Galvan +3 more
openaire +1 more source

